Aarti Industries Shifts Executive Control to Suyog Kotecha

Suyog Kotecha will become Managing Director and CEO of Aarti Industries from October 1, 2026.
Three promoter directors will move from executive positions to non-executive board roles on the same date.

Reader Takeaway: Professional management gains operating control, while execution on Zone IV and free cash flow remains the key test.

What just happened

Aarti Industries Limited is implementing a planned leadership succession that separates day-to-day executive management from promoter-led strategic oversight.

Rajendra V. Gogri, currently Chairman and Managing Director, will become Non-Executive Chairman from October 1. Rashesh C. Gogri and Renil R. Gogri will also transition out of executive responsibilities into non-executive board positions.

Suyog Kotecha will take over as Managing Director and CEO for a five-year term beginning October 1, subject to the approved corporate process. He has served as CEO and Executive Director and has been working with the board and management team on strategic execution and customer engagement.

Why this matters

The change is significant because executive responsibility is moving to professional management without removing promoter involvement from the board.

For shareholders, that creates a clear division: Kotecha and the executive team will be responsible for operating execution, while the promoter directors remain available for strategic guidance and long-term oversight.

The transition itself does not change the company's operating assets or financial targets. The market impact will depend on whether the new structure improves execution against the priorities management has already identified.

The backstory

Aarti Industries reported FY26 consolidated revenue of ₹9,018 crore, up 12% year-on-year. EBITDA rose 15% to ₹1,172 crore, while profit after tax increased 27% to ₹419 crore.

The company operates in specialty chemicals and has been working through capacity additions, customer diversification and tighter capital discipline. Kotecha has served as CEO since June 2024, making the MD and CEO appointment an expansion of his executive authority rather than an entry by an external leader unfamiliar with the business.

What changes now

Management's FY27 priorities include improving asset utilisation, commercialising Zone IV, scaling selected high-growth niches and expanding advanced chemistries.

Capital discipline is another stated focus. The company wants stronger customer partnerships, better capital efficiency and higher free cash flow generation as new capacities move toward commercial contribution.

Risks to watch

Leadership continuity reduces transition risk, but execution remains the central issue. Investors will need to track how quickly Zone IV contributes, whether utilisation improves across existing facilities and whether growth translates into stronger cash generation.

The promoter directors will retain strategic board roles, so the transition is not a withdrawal of promoter oversight. The key question is how effectively the company balances professional operating control with continuing promoter involvement.

What to track next

Shareholders should monitor Zone IV commercialisation, asset utilisation, free cash flow, capital efficiency and progress in higher-growth specialty chemistry segments after the new structure takes effect on October 1.